Viewing StudyNCT05431504

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 5:47 PM
Last Modification Date: 2024-10-26 @ 2:35 PM
Study NCT ID: NCT05431504
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-06-24
First Post: 2022-06-19
Brief Title: The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive HER2-negative Advanced Breast Cancer Patients With Visceral Crisis
Sponsor: Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization: Cancer Institute and Hospital Chinese Academy of Medical Sciences
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords: